ConductScience.org, home

Paper · 136102

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
145630451,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.Adv Cancer Res1972https://conductscience.org/library/papers/4563045PubMed
2123170Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.Cancer Res1975https://conductscience.org/library/papers/123170PubMed
34809457Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.Cancer Res1974https://conductscience.org/library/papers/4809457PubMed
41120307Chemotherapy of the transplantable acute leukemia L5222 in rats.Cancer Res1975https://conductscience.org/library/papers/1120307PubMed
55170822Synthesis of potential anticancer agents. 38. N-Nitrosoureas. 4. Further synthesis and evaluation of haloethyl derivatives.J Med Chem1971https://conductscience.org/library/papers/5170822PubMed
64280395[Modified streptozotocins].Helv Chim Acta1974https://conductscience.org/library/papers/4280395PubMed
7162855Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.Cancer Res1975https://conductscience.org/library/papers/162855PubMed
85007685Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro.Cancer Res1972https://conductscience.org/library/papers/5007685PubMed
95560387Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.Cancer Res1971https://conductscience.org/library/papers/5560387PubMed
106037060The modes of decomposition of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.J Med Chem1967https://conductscience.org/library/papers/6037060PubMed
1114184923THE SYNTHESIS OF ANTINEOPLASTIC AGENTS. XXXII. N-NITROSOUREAS. I.J Med Chem1963https://conductscience.org/library/papers/14184923PubMed
124855751Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate.Cancer Res1974https://conductscience.org/library/papers/4855751PubMed
135972051The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives.J Med Chem1966https://conductscience.org/library/papers/5972051PubMed
146037061The synthesis of potential anticancer agents. XXXVII. N-nitrosoureas. 3. 1,5-bis(2-chloroethyl)-1-nitrosobiuret and related derivatives of biurets, biureas, and carboxamides.J Med Chem1967https://conductscience.org/library/papers/6037061PubMed
15122802Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.J Med Chem1975https://conductscience.org/library/papers/122802PubMed
164987693The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.Cancer Res1970https://conductscience.org/library/papers/4987693PubMed
171151969Decomposition of N-(2-chloroethyl)-N-nitrosoureas in aqueous media.J Med Chem1975https://conductscience.org/library/papers/1151969PubMed
184230610[Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].Z Krebsforsch1967https://conductscience.org/library/papers/4230610PubMed
195081587Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles.Cancer Chemother Rep1972https://conductscience.org/library/papers/5081587PubMed
204829828[Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies].Blut1974https://conductscience.org/library/papers/4829828PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/136102/references